{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T04:42:27Z","timestamp":1785300147466,"version":"3.55.0"},"reference-count":50,"publisher":"American Association for Cancer Research (AACR)","issue":"3","funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["GL P30CA015704-45"],"award-info":[{"award-number":["GL P30CA015704-45"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["MAB P30CA014236"],"award-info":[{"award-number":["MAB P30CA014236"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["CRF T32-CA236621"],"award-info":[{"award-number":["CRF T32-CA236621"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["P30-CA046592"],"award-info":[{"award-number":["P30-CA046592"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["DPS P30-CA054174"],"award-info":[{"award-number":["DPS P30-CA054174"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,5,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Patients with B-lymphoid malignancies have been consistently identified as a population at high risk of severe COVID-19. Whether this is exclusively due to cancer-related deficits in humoral and cellular immunity, or whether risk of severe COVID-19 is increased by anticancer therapy, is uncertain. Using data derived from the COVID-19 and Cancer Consortium (CCC19), we show that patients treated for B-lymphoid malignancies have an increased risk of severe COVID-19 compared with control populations of patients with non\u2013B-lymphoid malignancies. Among patients with B-lymphoid malignancies, those who received anticancer therapy within 12 months of COVID-19 diagnosis experienced increased COVID-19 severity compared with patients with non\u2013recently treated B-lymphoid malignancies, after adjustment for cancer status and several other prognostic factors. Our findings suggest that patients recently treated for a B-lymphoid malignancy are at uniquely high risk for severe COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Our study suggests that recent therapy for a B-lymphoid malignancy is an independent risk factor for COVID-19 severity. These findings provide rationale to develop mitigation strategies targeted at the uniquely high-risk population of patients with recently treated B-lymphoid malignancies.<\/jats:p>\n                    <jats:p>This article is highlighted in the In This Issue feature, p. 171<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2643-3230.bcd-22-0013","type":"journal-article","created":{"date-parts":[[2022,3,9]],"date-time":"2022-03-09T11:35:51Z","timestamp":1646825751000},"page":"181-193","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19"],"prefix":"10.1158","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5568-4441","authenticated-orcid":false,"given":"Samuel M.","family":"Rubinstein","sequence":"first","affiliation":[{"name":"1Division of Hematology, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divaya","family":"Bhutani","sequence":"additional","affiliation":[{"name":"2Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan C.","family":"Lynch","sequence":"additional","affiliation":[{"name":"3Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Yuan","family":"Hsu","sequence":"additional","affiliation":[{"name":"4Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Shyr","sequence":"additional","affiliation":[{"name":"4Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee."},{"name":"5Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailesh","family":"Advani","sequence":"additional","affiliation":[{"name":"6Cancer Prevention and Control, Department of Oncology, Georgetown University School of Medicine, Georgetown University, Washington D.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5880-7972","authenticated-orcid":false,"given":"Ruben A.","family":"Mesa","sequence":"additional","affiliation":[{"name":"7Mays Cancer Center, UT Health San Antonio MD Anderson, San Antonio, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7775-9600","authenticated-orcid":false,"given":"Sanjay","family":"Mishra","sequence":"additional","affiliation":[{"name":"8Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"Mundt","sequence":"additional","affiliation":[{"name":"9Aurora Cancer Care, Advocate Aurora Health, Milwaukee, Wisconsin."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9019-8310","authenticated-orcid":false,"given":"Dimpy P.","family":"Shah","sequence":"additional","affiliation":[{"name":"7Mays Cancer Center, UT Health San Antonio MD Anderson, San Antonio, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8877-4470","authenticated-orcid":false,"given":"R. Alejandro","family":"Sica","sequence":"additional","affiliation":[{"name":"10Division of Hematology and Oncology, Montefiore Medical Center\/Albert Einstein College of Medicine, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7234-1715","authenticated-orcid":false,"given":"Keith E.","family":"Stockerl-Goldstein","sequence":"additional","affiliation":[{"name":"11Division of Oncology, Washington University, Saint Louis, Missouri."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1841-4565","authenticated-orcid":false,"given":"Catherine","family":"Stratton","sequence":"additional","affiliation":[{"name":"12Division of Hematology and Oncology, Yale University, New Haven, Connecticut."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Weiss","sequence":"additional","affiliation":[{"name":"13Thedacare, Appleton, Wisconsin."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Beeghly-Fadiel","sequence":"additional","affiliation":[{"name":"5Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4156-7279","authenticated-orcid":false,"given":"Melissa","family":"Accordino","sequence":"additional","affiliation":[{"name":"2Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarit E.","family":"Assouline","sequence":"additional","affiliation":[{"name":"14Division of Hematology, McGill University, Jewish General Hospital, Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6074-4771","authenticated-orcid":false,"given":"Joy","family":"Awosika","sequence":"additional","affiliation":[{"name":"15University of Cincinnati Cancer Center, Cincinnati, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1906-5704","authenticated-orcid":false,"given":"Ziad","family":"Bakouny","sequence":"additional","affiliation":[{"name":"16Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6843-1179","authenticated-orcid":false,"given":"Babar","family":"Bashir","sequence":"additional","affiliation":[{"name":"17Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-5350","authenticated-orcid":false,"given":"Stephanie","family":"Berg","sequence":"additional","affiliation":[{"name":"18Division of Hematology and Oncology, Loyola University Medical Center, Hines, Illinois."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Asim","family":"Bilen","sequence":"additional","affiliation":[{"name":"19Winship Cancer Institute of Emory University, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia A.","family":"Castellano","sequence":"additional","affiliation":[{"name":"19Winship Cancer Institute of Emory University, Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob C.","family":"Cogan","sequence":"additional","affiliation":[{"name":"2Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devendra","family":"KC","sequence":"additional","affiliation":[{"name":"20Hartford HealthCare Cancer Institute, Hartford, Connecticut."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2281-2056","authenticated-orcid":false,"given":"Christopher R.","family":"Friese","sequence":"additional","affiliation":[{"name":"21University of Michigan Rogel Cancer Center, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Gupta","sequence":"additional","affiliation":[{"name":"22Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9139-5938","authenticated-orcid":false,"given":"Daniel","family":"Hausrath","sequence":"additional","affiliation":[{"name":"8Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0998-323X","authenticated-orcid":false,"given":"Clara","family":"Hwang","sequence":"additional","affiliation":[{"name":"23Henry Ford Cancer Institute, Henry Ford Hospital, Detroit, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie A.","family":"Johnson","sequence":"additional","affiliation":[{"name":"14Division of Hematology, McGill University, Jewish General Hospital, Montreal, Quebec, Canada."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Joshi","sequence":"additional","affiliation":[{"name":"24Penn State Health\/Penn State Cancer Institute\/St. Joseph Cancer Center, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4305-5701","authenticated-orcid":false,"given":"Anup","family":"Kasi","sequence":"additional","affiliation":[{"name":"25The University of Kansas Cancer Center, Kansas City, Kansas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Klein","sequence":"additional","affiliation":[{"name":"26Brown University and Lifespan Cancer Institute, Providence, Rhode Island."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2277-8668","authenticated-orcid":false,"given":"Vadim S.","family":"Koshkin","sequence":"additional","affiliation":[{"name":"27Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Kuderer","sequence":"additional","affiliation":[{"name":"28Advanced Cancer Research Group, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0830-7918","authenticated-orcid":false,"given":"Daniel H.","family":"Kwon","sequence":"additional","affiliation":[{"name":"27Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9584-8455","authenticated-orcid":false,"given":"Chris","family":"Labaki","sequence":"additional","affiliation":[{"name":"16Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir","family":"Latif","sequence":"additional","affiliation":[{"name":"15University of Cincinnati Cancer Center, Cincinnati, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8777-170X","authenticated-orcid":false,"given":"Eric","family":"Lau","sequence":"additional","affiliation":[{"name":"29Division of Medical Oncology and Hematology, Loma Linda University, Loma Linda, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanyi","family":"Li","sequence":"additional","affiliation":[{"name":"8Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0823-8086","authenticated-orcid":false,"given":"Gary H.","family":"Lyman","sequence":"additional","affiliation":[{"name":"30Fred Hutchinson Cancer Research Center, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana R.","family":"McKay","sequence":"additional","affiliation":[{"name":"31Moores Comprehensive Cancer Center, University of California, San Diego, San Diego, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7586-6920","authenticated-orcid":false,"given":"Gayathri","family":"Nagaraj","sequence":"additional","affiliation":[{"name":"29Division of Medical Oncology and Hematology, Loma Linda University, Loma Linda, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Nizam","sequence":"additional","affiliation":[{"name":"22Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor K.","family":"Nonato","sequence":"additional","affiliation":[{"name":"31Moores Comprehensive Cancer Center, University of California, San Diego, San Diego, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6472-6658","authenticated-orcid":false,"given":"Adam J.","family":"Olszewski","sequence":"additional","affiliation":[{"name":"26Brown University and Lifespan Cancer Institute, Providence, Rhode Island."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyma V.","family":"Polimera","sequence":"additional","affiliation":[{"name":"24Penn State Health\/Penn State Cancer Institute\/St. Joseph Cancer Center, Philadelphia, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1010-4578","authenticated-orcid":false,"given":"Andrew J.","family":"Portuguese","sequence":"additional","affiliation":[{"name":"3Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9281-2262","authenticated-orcid":false,"given":"Matthew M.","family":"Puc","sequence":"additional","affiliation":[{"name":"32Virtua Health, Marlton, New Jersey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Razavi","sequence":"additional","affiliation":[{"name":"31Moores Comprehensive Cancer Center, University of California, San Diego, San Diego, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Rosovski","sequence":"additional","affiliation":[{"name":"33Division of Hematology, Massachusetts General Hospital, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4930-4155","authenticated-orcid":false,"given":"Andrew","family":"Schmidt","sequence":"additional","affiliation":[{"name":"16Dana-Farber Cancer Institute, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit A.","family":"Shah","sequence":"additional","affiliation":[{"name":"34Stanford Cancer Institute at Stanford University, Stanford, California."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Shastri","sequence":"additional","affiliation":[{"name":"10Division of Hematology and Oncology, Montefiore Medical Center\/Albert Einstein College of Medicine, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2700-2650","authenticated-orcid":false,"given":"Christopher","family":"Su","sequence":"additional","affiliation":[{"name":"21University of Michigan Rogel Cancer Center, Ann Arbor, Michigan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1681-5883","authenticated-orcid":false,"given":"Pallawi","family":"Torka","sequence":"additional","affiliation":[{"name":"35Roswell Park Comprehensive Cancer Center, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7279-4028","authenticated-orcid":false,"given":"Trisha M.","family":"Wise-Draper","sequence":"additional","affiliation":[{"name":"15University of Cincinnati Cancer Center, Cincinnati, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4226-7443","authenticated-orcid":false,"given":"Leyre","family":"Zubiri","sequence":"additional","affiliation":[{"name":"32Virtua Health, Marlton, New Jersey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2851-7242","authenticated-orcid":false,"given":"Jeremy L.","family":"Warner","sequence":"additional","affiliation":[{"name":"5Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee."},{"name":"36Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, Tennessee."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7930-4610","authenticated-orcid":false,"given":"Michael A.","family":"Thompson","sequence":"additional","affiliation":[{"name":"9Aurora Cancer Care, Advocate Aurora Health, Milwaukee, Wisconsin."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the COVID-19 and Cancer Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2022,3,9]]},"reference":[{"key":"2025112416515568700_bib1","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1056\/NEJMra041875","article-title":"Multiple myeloma","volume":"351","author":"Kyle","year":"2004","journal-title":"N Engl J Med"},{"key":"2025112416515568700_bib2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/irv.12170","article-title":"Influenza prevention and treatment in transplant recipients and immunocompromised hosts","volume":"7","author":"Ison","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"2025112416515568700_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/978-3-319-04220-6_11","article-title":"Infections in patients with leukemia and lymphoma [Internet]","volume-title":"Infectious complications in cancer patients","author":"Morrison","year":"2014"},{"key":"2025112416515568700_bib4","doi-asserted-by":"crossref","first-page":"9219","DOI":"10.1200\/JCO.2005.03.2086","article-title":"Early mortality after diagnosis of multiple myeloma: analysis of patients entered onto the United Kingdom Medical Research Council trials between 1980 and 2002\u2014Medical Research Council Adult Leukaemia Working Party","volume":"23","author":"Augustson","year":"2005","journal-title":"J Clin Oncol"},{"key":"2025112416515568700_bib5","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S1470-2045(20)30310-7","article-title":"Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study","volume":"21","author":"Yang","year":"2020","journal-title":"Lancet Oncol"},{"key":"2025112416515568700_bib6","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1038\/s41375-020-0836-7","article-title":"COVID-19 in persons with haematological cancers","volume":"34","author":"He","year":"2020","journal-title":"Leukemia"},{"key":"2025112416515568700_bib7","doi-asserted-by":"crossref","first-page":"e737","DOI":"10.1016\/S2352-3026(20)30251-9","article-title":"Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study","volume":"7","author":"Passamonti","year":"2020","journal-title":"Lancet Haematol"},{"key":"2025112416515568700_bib8","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1182\/blood.2020008824","article-title":"Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients","volume":"136","author":"Vijenthira","year":"2020","journal-title":"Blood"},{"key":"2025112416515568700_bib9","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.annonc.2020.03.296","article-title":"Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China","volume":"31","author":"Zhang","year":"2020","journal-title":"Ann Oncol"},{"key":"2025112416515568700_bib10","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"2025112416515568700_bib11","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1182\/blood.2020006965","article-title":"Outcomes of COVID-19 in patients with CLL: a multicenter international experience","volume":"136","author":"Mato","year":"2020","journal-title":"Blood"},{"key":"2025112416515568700_bib12","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0140-6736(20)31173-9","article-title":"COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study","volume":"395","author":"Lee","year":"2020","journal-title":"Lancet"},{"key":"2025112416515568700_bib13","doi-asserted-by":"crossref","first-page":"100549","DOI":"10.1016\/j.eclinm.2020.100549","article-title":"Determinants of outcome in Covid-19 hospitalized patients with lymphoma: a retrospective multicentric cohort study","volume":"27","author":"Lamure","year":"2020","journal-title":"EClinicalMedicine"},{"key":"2025112416515568700_bib14","doi-asserted-by":"crossref","first-page":"e185","DOI":"10.1016\/S2352-3026(20)30429-4","article-title":"Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study","volume":"8","author":"Sharma","year":"2021","journal-title":"Lancet Haematol"},{"key":"2025112416515568700_bib15","article-title":"BTK inhibitors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a systematic review","author":"Stack","year":"2021","journal-title":"Res Sq"},{"key":"2025112416515568700_bib16","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1200\/JCO.20.01580","article-title":"COVID-19 severity and outcomes in patients with cancer: a matched cohort study","volume":"38","author":"Brar","year":"2020","journal-title":"J Clin Oncol"},{"key":"2025112416515568700_bib17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.annonc.2021.02.024","article-title":"Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium","volume":"32","author":"Grivas","year":"2021","journal-title":"Ann Oncol"},{"key":"2025112416515568700_bib18","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1182\/bloodadvances.2021005444","article-title":"Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study","volume":"5","author":"Gavriatopoulou","year":"2021","journal-title":"Blood Adv"},{"key":"2025112416515568700_bib19","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1182\/blood.2021011568","article-title":"Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia","volume":"137","author":"Herishanu","year":"2021","journal-title":"Blood"},{"key":"2025112416515568700_bib20","article-title":"Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority guidelines","author":"Monin-Aldama","year":"2021","journal-title":"medRxiv"},{"key":"2025112416515568700_bib21","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ccell.2021.07.012","article-title":"Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies","volume":"39","author":"Greenberger","year":"2021","journal-title":"Cancer Cell"},{"key":"2025112416515568700_bib22","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1158\/2643-3230.BCD-21-0139","article-title":"Disease-and therapy-specific impact on humoral immune responses to COVID-19 vaccination in hematologic malignancies","volume":"2","author":"Chung","year":"2021","journal-title":"Blood Cancer Discov"},{"key":"2025112416515568700_bib23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5501\/wjv.v10.i6.312","article-title":"COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review","volume":"10","author":"Bonuomo","year":"2021","journal-title":"World J Virol"},{"key":"2025112416515568700_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.5501\/wjv.v10.i3.97","article-title":"Impact of COVID-19 in patients with lymphoid malignancies","volume":"10","author":"Riches","year":"2021","journal-title":"World J Virol"},{"key":"2025112416515568700_bib25","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study","volume":"395","author":"Kuderer","year":"2020","journal-title":"Lancet"},{"key":"2025112416515568700_bib26","article-title":"Key findings from the UKCCMP cohort of 877 patients with haematological malignancy and COVID-19: disease control as an important factor relative to recent chemotherapy or anti-CD20 therapy [Internet]","author":"Booth","year":"2021","journal-title":"Br J Haematol"},{"key":"2025112416515568700_bib27","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1158\/2159-8290.CD-21-1368","article-title":"Learning through a pandemic: the current state of knowledge on COVID-19 and cancer [Internet]","volume":"12","author":"Elkrief","year":"2022","journal-title":"Cancer Discov"},{"key":"2025112416515568700_bib28","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0140-6736(22)00017-4","article-title":"Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study","volume":"399","author":"Wolter","year":"2022","journal-title":"Lancet"},{"key":"2025112416515568700_bib29","doi-asserted-by":"crossref","first-page":"5966","DOI":"10.1182\/bloodadvances.2020003170","article-title":"Outcomes of patients with hematologic malignancies and COVID-19: a report from the ASH Research Collaborative Data Hub","volume":"4","author":"Wood","year":"2020","journal-title":"Blood Adv"},{"key":"2025112416515568700_bib30","first-page":"OP2100394","article-title":"Changes over time in COVID-19 severity and mortality in patients undergoing cancer treatment in the United States: initial report from the ASCO registry","author":"Mileham","year":"2021","journal-title":"JCO Oncol Pract"},{"key":"2025112416515568700_bib31","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.dsx.2020.05.017","article-title":"Hydroxychloroquine in patients with COVID-19: a systematic review and meta-analysis","volume":"14","author":"Singh","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"2025112416515568700_bib32","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1001\/jama.2020.8630","article-title":"Association of treatment with hydroxychloroquine or azithromycin with in-hospital mortality in patients with COVID-19 in New York State","volume":"323","author":"Rosenberg","year":"2020","journal-title":"JAMA"},{"key":"2025112416515568700_bib33","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jama.2021.0202","article-title":"Effect of bamlanivimab as monotherapy or in combination with etesevimab on viral load in patients with mild to moderate COVID-19: a randomized clinical trial","volume":"325","author":"Gottlieb","year":"2021","journal-title":"JAMA"},{"key":"2025112416515568700_bib34","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of Covid-19","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"key":"2025112416515568700_bib35","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19","volume":"384","author":"RECOVERY Collaborative Group","year":"2021","journal-title":"N Engl J Med"},{"key":"2025112416515568700_bib36","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/infdis\/jiab406","article-title":"Severe acute respiratory syndrome coronavirus 2-specific monoclonal antibody for the treatment of mild to moderate coronavirus disease 2019 in cancer patients: a single-center experience","volume":"225","author":"Puing","year":"2022","journal-title":"J Infect Dis"},{"key":"2025112416515568700_bib37","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1001\/jamaoncol.2021.4083","article-title":"COVID-19 and cancer: a review of the registry-based pandemic response","volume":"7","author":"Desai","year":"2021","journal-title":"JAMA Oncol"},{"key":"2025112416515568700_bib38","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ccell.2020.04.018","article-title":"The COVID-19 and cancer consortium: a collaborative effort to understand the effects of COVID-19 on patients with cancer","volume":"37","author":"Rubinstein","year":"2020","journal-title":"Cancer Cell"},{"key":"2025112416515568700_bib39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.ccell.2020.09.018","article-title":"COVID-19 and cancer: current challenges and perspectives","volume":"38","author":"Bakouny","year":"2020","journal-title":"Cancer Cell"},{"key":"2025112416515568700_bib40","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s43018-020-0065-z","article-title":"Crowdsourcing a crisis response for COVID-19 in oncology","volume":"1","author":"Desai","year":"2020","journal-title":"Nat Cancer"},{"key":"2025112416515568700_bib41","doi-asserted-by":"crossref","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"key":"2025112416515568700_bib42","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"2025112416515568700_bib43","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1158\/2159-8290.CD-20-0941","article-title":"Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and Cancer Consortium (CCC19) Cohort Study","volume":"10","author":"Rivera","year":"2020","journal-title":"Cancer Discov"},{"key":"2025112416515568700_bib44","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.clim.2006.08.009","article-title":"B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny","volume":"122","author":"Anolik","year":"2007","journal-title":"Clin Immunol"},{"key":"2025112416515568700_bib45","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/hon.947","article-title":"Immune reconstitution of B-cell lymphoma patients receiving CHOP-based chemotherapy containing rituximab","volume":"29","author":"Kurokawa","year":"2011","journal-title":"Hematol Oncol"},{"key":"2025112416515568700_bib46","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1158\/2643-3230.BCD-21-0222","article-title":"CD20-targeted therapy ablates de novo antibody response to vaccination but spares preestablished immunity","volume":"3","author":"Shree","year":"2022","journal-title":"Blood Cancer Discov"},{"key":"2025112416515568700_bib47","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/S0895-4356(00)00256-0","article-title":"Development of a comorbidity index using physician claims data","volume":"53","author":"Klabunde","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"2025112416515568700_bib48","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1475-6773.2011.01314.x","article-title":"Interaction terms in nonlinear models","volume":"47","author":"Karaca-Mandic","year":"2012","journal-title":"Health Serv Res"},{"key":"2025112416515568700_bib49","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/jamaoncol.2021.1799","article-title":"Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19","volume":"7","author":"Thompson","year":"2021","journal-title":"JAMA Oncol"},{"key":"2025112416515568700_bib50","doi-asserted-by":"crossref","first-page":"103239","DOI":"10.1016\/j.jbi.2019.103239","article-title":"HemOnc: a new standard vocabulary for chemotherapy regimen representation in the OMOP common data model","volume":"96","author":"Warner","year":"2019","journal-title":"J Biomed Inform"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-22-0013\/3054806\/bcd-22-0013.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-22-0013\/3109156\/bcd-22-0013.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/3\/3\/181\/3186322\/181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/3\/3\/181\/3186322\/181.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T21:52:09Z","timestamp":1764021129000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/3\/3\/181\/694688\/Patients-Recently-Treated-for-B-lymphoid"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,9]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3,9]]},"published-print":{"date-parts":[[2022,5,5]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-22-0013","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/2643-3230.22544427.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.c.6550638.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2643-3230.c.6550638","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2643-3230.22544427","asserted-by":"object"}]},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,9]]}}}